The microbiology of ventilator-associated pneumonia

Respiratory Care

Volumn 50, Issue 6, 2005, Pages 742-763

  Park, David R ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Antibiotic; Antibiotic resistant; Bacteria; Mechanical ventilation; Microbiology; Nosocomial; Pathogen; Pneumonia; Ventilator associated pneumonia

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFTAZIDIME; IMIPENEM; INFLUENZA VACCINE; PIPERACILLIN PLUS TAZOBACTAM; ANTIINFECTIVE AGENT;

ACUTE RESPIRATORY FAILURE; ANTIBIOTIC RESISTANCE; ARTIFICIAL VENTILATION; BURN; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFERENCE PAPER; FUNGUS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HOSPITAL COST; HOSPITAL PATIENT; HUMAN; IMMUNOCOMPROMISED PATIENT; INFLUENZA; INJURY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROFLORA; MORBIDITY; MORTALITY; MYCOPLASMA; PATHOGENESIS; TRACHEOSTOMY; VENTILATOR ASSOCIATED PNEUMONIA; VIRUS; CROSS INFECTION; ISOLATION AND PURIFICATION; LEGIONELLA; MICROBIOLOGY; PATHOGENICITY; PNEUMONIA; REVIEW; VENTILATOR; VIROLOGY;

ANTI-BACTERIAL AGENTS; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; FUNGI; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; LEGIONELLA; MYCOPLASMA; PNEUMONIA; VENTILATORS, MECHANICAL; VIRUSES;

EID: 27244449960     PISSN: 00201324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (188)

1. Kollef MH. The importance of appropriate initial antibiotic therapy for hospital-acquired infections. Am J Med 2003;115(7):582-584.
2. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005;171(4):388-416.
3. Yu VL, Singh N. Excessive antimicrobial usage causes measurable harm to patients with suspected ventilator-associated pneumonia. Intensive Care Med 2004;30(5):735-738.
4. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002;165(7):867-903.
5. Meduri GU, Mauldin GL, Wunderink RG, Leeper KV Jr, Jones CB, Tolley E, Mayhall G. Causes of fever and pulmonary densities in patients with clinical manifestations of ventilator-associated pneumonia. Chest 1994;106(1):221-235.
6. 5a. Park DR. Antimicrobial treatment of ventilator-associated pneumonia. Respir Care 2005;50(7). In press.
7. Rouby JJ, Martin De Lassale E, Poete P, Nicolas MH, Bodin L, Jarlier V, et al. Nosocomial bronchopneumonia in the critically ill. Histologic and bacteriologic aspects. Am Rev Respir Dis 1992; 146(4):1059-1066.
8. Valles J, Artigas A, Rello J, Bonsoms N, Fontanals D, Blanch L, et al. Continuous aspiration of subglottic secretions in preventing ventilator-associated pneumonia. Ann Intern Med 1995;122(3):179-186.
9. Niederman MS. Bacterial adherence as a mechanism of airway colonization. Eur J Clin Microbiol Infect Dis 1989;8(1):15-20.
10. Niederman MS, Mantovani R, Schoch P, Papas J, Fein AM. Patterns and routes of tracheobronchial colonization in mechanically ventilated patients. The role of nutritional status in colonization of the lower airway by Pseudomonas species. Chest 1989;95(1):155-161.
11. Dreyfuss D, Djedaini K, Weber P, Brun P, Lanore JJ, Rahmani J, et al. Prospective study of nosocomial pneumonia and of patient and circuit colonization during mechanical ventilation with circuit changes every 48 hours versus no change. Am Rev Respir Dis 1991;143(4Pt 1):738-743.
12. Bonten MJ, Bergmans DC, Ambergen AW, de Leeuw PW, van der Geest S, Stobberingh EE, et al. Risk factors for pneumonia, and colonization of respiratory tract and stomach in mechanically ventilated ICU patients. Am J Respir Crit Care Med 1996;154(5): 1339-1346.
13. Estes RJ, Meduri GU. The pathogenesis of ventilator-associated pneumonia: I. Mechanisms of bacterial transcolonization and airway inoculation. Intensive Care Med 1995;21(4):365-383.
14. Meduri GU, Estes RJ. The pathogenesis of ventilator-associated pneumonia: II. The lower respiratory tract. Intensive Care Med 1995;21(5):452-461.
15. Bonten MJ, Gaillard CA, de Leeuw PW, Stobberingh EE. Role of colonization of the upper intestinal tract in the pathogenesis of ventilator-associated pneumonia. Clin Infect Dis 1997;24(3):309-319.
16. Johanson WG, Pierce AK, Sanford JP. Changing pharyngeal bacterial flora of hospitalized patients. Emergence of Gram-negative bacilli. N Engl J Med 1969;281(21):1137-1140.
17. Johanson WG Jr, Pierce AK, Sanford JP, Thomas GD. Nosocomial respiratory infections with Gram-negative bacilli. The significance of colonization of the respiratory tract. Ann Intern Med 1972;77(5): 701-706.
18. Tillotson JR, Finland M. Bacterial colonization and clinical super-infection of the respiratory tract complicating antibiotic treatment of pneumonia. J Infect Dis 1969;119(6):597-624.
19. Kneeland Y Jr, Price KM. Antibiotics and terminal pneumonia. A postmortem microbiological study. Am J Med 1960;29:967-979.
20. Hospital-acquired pneumonia in adults: Diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. A consensus statement, American Thoracic Society, November 1995. Am J Respir Crit Care Med 1996;153(5):1711-1725.
21. Musher DM. Infections caused by Streptococcus pneumoniae: clinical spectrum, pathogenesis, immunity, and treatment. Clin Infect Dis 1992;14(4):801-807.
22. Doern GV, Brown SD. Antimicrobial susceptibility among community-acquired respiratory tract pathogens in the USA: Data from PROTEKT US 2000-01. J Infect 2004;48(1):56-65.
23. Beekmann SE, Heilmann KP, Richter SS, Garcia-de-Lomas J, Doern GV; The GRASP Study Group. Antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and group A beta-haemolytic streptococci in 2002-2003. Results of the multinational GRASP Surveillance Program. Int J Antimicrob Agents 2005;25(2):148-156.
24. Pallares R, Linares J, Vadillo M, Cabellos C, Manresa F, Viladrich PF, et al. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med 1995;333(8):474-480.
25. Pallares R, Capdevila O, Linares J, Grau I, Onaga H, Tubau F, et al. The effect of cephalosporin resistance on mortality in adult patients with nonmeningeal systemic pneumococcal infections. Am J Med 2002;113(2):120-126.
26. Paradisi F, Corti G, Cinelli R. Streptococcus pneumoniae as an agent of nosocomial infection: treatment in the era of penicillin-resistant strains. Clin Microbiol Infect 2001;7 Suppl 4:34-42.
27. Dennesen PJ, van der Ven AJ, Kessels AG, Ramsay G, Bonten MJ. Resolution of infectious parameters after antimicrobial therapy in patients with ventilator-associated pneumonia. Am J Respir Crit Care Med 2001;163(6):1371- 1375.
28. Rello J, Ausina V, Ricart M, Castella J, Prats G. Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia. Chest 1993;104(4):1230-1235.
29. Marrs CF, Krasan GP, McCrea KW, Clemans DL, Gilsdorf JR. Haemophilus influenzae-human specific bacteria. Front Biosci 2001;6:E41-60.
30. Rello J, Ricart M, Ausina V, Net A, Prats G. Pneumonia due to Haemophilus influenzae among mechanically ventilated patients. Incidence, outcome, and risk factors. Chest 1992;102(5):1562-1565.
31. Shah PM. Staphylococcus aureus in lower respiratory infections: Clinical relevance of antimicrobial resistance. Semin Respir Infect 2001;16(3):196-202.
32. Stevens DL. Community-acquired Staphylococcus aureus infections: Increasing virulence and emerging methicillin resistance in the new millennium. Curr Opin Infect Dis 2003;16(3):189-191.
33. Rello J, Quintana E, Ausina V, Puzo C, Net A, Prats G. Risk factors for Staphylococcus aureus nosocomial pneumonia in critically ill patients. Am Rev Respir Dis 1990;142(6 Pt 1):1320-1324.
34. Antonelli M, Moro ML, Capelli O, De Blasi RA, D'Errico RR, Conti G, et al. Risk factors for early onset pneumonia in trauma patients. Chest 1994;105(1):224-228.
35. Baker AM, Meredith JW, Haponik EF. Pneumonia in intubated trauma patients. Microbiology and outcomes. Am J Respir Crit Care Med 1996;153(1):343-349.
36. Pujol M, Corbella X, Pena C, Pallares R, Dorca J, Verdaguer R, et al. Clinical and epidemiological findings in mechanically-ventilated patients with methicillin-resistant Staphylococcus aureus pneumonia. Eur J Clin Microbiol Infect Dis 1998;17(9):622-628.
37. Rello J, Torres A, Ricart M, Valles J, Gonzalez J, Artigas A, Rodriguez-Roisin R. Ventilator-associated pneumonia by Staphylococcus aureus. Comparison of methicillin-resistant and methicillin-sensitive episodes. Am J Respir Crit Care Med 1994;150(6 Pt 1): 1545-1549.
38. Archer GL. Staphylococcus aureus: a well-armed pathogen. Clin Infect Dis 1998;26(5):1179-1181.
39. Holden MT, Feil EJ, Lindsay JA, Peacock SJ, Day NP, Enright MC, et al. Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance. Proc Natl Acad Sci U S A 2004;101(26):9785-9791.
40. Lindsay JA, Holden MT. Staphylococcus aureus: superbug, super genome? Trends Microbiol 2004;12(8):378-385.
41. Vandenesch F, Naimi T, Enright MC, Lina G, Nimmo GR, Heffernan H, et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: Worldwide emergence. Emerg Infect Dis 2003;9(8):978-984.
42. Lina G, Piemont Y, Godail-Gamot F, Bes M, Peter MO, Gauduchon V, et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 1999;29(5):1128-1132.
43. Gillet Y, Issartel B, Vanhems P, Fournet JC, Lina G, Bes M, et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 2002;359(9308): 753-759.
44. Klein JL, Petrovic Z, Treacher D, Edgeworth J. Severe community-acquired pneumonia caused by Panton-Valentine leukocidin-positive Staphylococcus aureus: first reported case in the United Kingdom. Intensive Care Med 2003;29(8):1399.
45. Naimi TS, LeDell KH, Como-Sabetti K, Borchardt SM, Boxrud DJ, Etienne J, et al. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 2003;290(22):2976-2984.
46. Bradford PA. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001;14(4):933-951.
47. Rupp ME, Fey PD. Extended spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae: considerations for diagnosis, prevention and drug treatment. Drugs 2003;63(4):353-365.
48. Colodner R. Extended-spectrum beta-lactamases: a challenge for clinical microbiologists and infection control specialists. Am J Infect Control 2005;33(2):104-107.
49. Fagon JY, Chastre J, Domart Y, Trouillet JL, Pierre J, Darne C, Gibert C. Nosocomial pneumonia in patients receiving continuous mechanical ventilation. Prospective analysis of 52 episodes with use of a protected specimen brush and quantitative culture techniques. Am Rev Respir Dis 1989;139(4):877-884.
50. Kollef MH, Silver P, Murphy DM, Trovillion E. The effect of late-onset ventilator-associated pneumonia in determining patient mortality. Chest 1995;108(6):1655-1662.
51. Rello J, Jubert P, Valles J, Artigas A, Rue M, Niederman MS. Evaluation of outcome for intubated patients with pneumonia due to Pseudomonas aeruginosa. Clin Infect Dis 1996;23(5):973-978.
52. Crouch Brewer S, Wunderink RG, Jones CB, Leeper KV Jr. Ventilator-associated pneumonia due to Pseudomonas aeruginosa. Chest 1996;109(4):1019-1029.
53. Rello J, Rue M, Jubert P, Muses G, Sonora R, Valles J, Niederman MS. Survival in patients with nosocomial pneumonia: impact of the severity of illness and the etiologic agent. Crit Care Med 1997; 25(11):1862-1867.
54. Rello J, Ausina V, Ricart M, Puzo C, Quintana E, Net A, Prats G. Risk factors for infection by Pseudomonas aeruginosa in patients with ventilator-associated pneumonia. Intensive Care Med 1994; 20(3):193-198.
55. Rello J, Mariscal D, March F, Jubert P, Sanchez F, Valles J, Coll P. Recurrent Pseudomonas aeruginosa pneumonia in ventilated patients: relapse or reinfection? Am J Respir Crit Care Med 1998; 157(3 Pt 1):912-916.
56. Combes A, Figliolini C, Trouillet JL, Kassis N, Dombret MC, Wolff M, et al. Factors predicting ventilator-associated pneumonia recurrence. Crit Care Med 2003;31(4):1102-1107.
57. Sadikot RT, Blackwell TS, Christman JW, Prince AS. Pathogen-host interactions in Pseudomonas aeruginosa pneumonia: the state of the art. Am J Respir Crit Care Med 2005 Feb 1; [Epub ahead of print].
58. Galan JE, Collmer A. Type III secretion machines: bacterial devices for protein delivery into host cells. Science 1999;284(5418): 1322-1328.
59. Roy-Burman A, Savel RH, Racine S, Swanson BL, Revadigar NS, Fujimoto J, et al. Type III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa infections. J Infect Dis 2001;183(12):1767-1774.
60. Hauser AR, Cobb E, Bodi M, Mariscal D, Valles J, Engel JN, Rello J. Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosa. Crit Care Med 2002;30(3):521-528.
61. Schulert GS, Feltman H, Rabin SD, Martin CG, Battle SE, Rello J, Hauser AR. Secretion of the toxin ExoU is a marker for highly virulent Pseudomonas aeruginosa isolates obtained from patients with hospital-acquired pneumonia. J Infect Dis 2003;188(11):1695-1706.
62. Marra A. Can virulence factors be viable antibacterial targets? Expert Rev Anti Infect Ther 2004;2(1):61-72.
63. Jain R, Danziger LH. Multidrug-resistant acinetobacter infections: an emerging challenge to clinicians. Ann Pharmacother 2004;38(9): 1449-1459.
64. Seifert H, Strate A, Pulverer G. Nosocomial bacteremia due to Acinetobacter baumannii. Clinical features, epidemiology, and predictors of mortality. Medicine (Baltimore) 1995;74(6):340-349.
65. Bergogne-Berezin E, Towner KJ. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev 1996;9(2):148-165.
66. Chastre J, Trouillet JL. Problem pathogens (Pseudomonas aeruginosa and Acinetobacter). Semin Respir Infect 2000;15(4):287-298.
67. D'Agata EM, Thayer V, Schaffner W. An outbreak of Acinetobacter baumannii: the importance of cross-transmission. Infect Control Hosp Epidemiol 2000;21(9):588-591.
68. Simor AE, Lee M, Vearncombe M, Jones-Paul L, Barry C, Gomez M, et al. An outbreak due to multiresistant Acinetobacter baumannii in a burn unit: risk factors for acquisition and management. Infect Control Hosp Epidemiol 2002;23(5):261-267.
69. Garnacho J, Sole-Violan J, Sa-Borges M, Diaz E, Rello J. Clinical impact of pneumonia caused by Acinetobacter baumannii in intubated patients: a matched cohort study. Crit Care Med 2003;31(10): 2478-2482.
70. Montero A, Corbella X, Ariza J. Clinical relevance of Acinetobacter baumannii ventilator-associated pneumonia. Crit Care Med 2003;31(10):2557-2559.
71. Larson EL. Persistent carriage of Gram-negative bacteria on hands. Am J Infect Control 1981;9(4):112-119.
72. Getchell-White SI, Donowitz LG, Groschel DH. The inanimate environment of an intensive care unit as a potential source of nosocomial bacteria: Evidence for long survival of Acinetobacter calcoaceticus. Infect Control Hosp Epidemiol 1989;10(9):402-407.
73. Jawad A, Seifert H, Snelling AM, Heritage J, Hawkey PM. Survival of Acinetobacter baumannii on dry surfaces: comparison of outbreak and sporadic isolates. J Clin Microbiol 1998;36(7):1938-1941.
74. Roberts SA, Findlay R, Lang SD. Investigation of an outbreak of multi-drug resistant Acinetobacter baumannii in an intensive care burns unit. J Hosp Infect 2001;48(3):228-232.
75. Seifert H, Baginski R, Schulze A, Pulverer G. Antimicrobial susceptibility of Acinetobacter species. Antimicrob Agents Chemother 1993;37(4):750-753.
76. Manikal VM, Landman D, Saurina G, Oydna E, Lal H, Quale J. Endemic carbapenem-resistant Acinetobacter species in Brooklyn, New York: citywide prevalence, interinstitutional spread, and relation to antibiotic usage. Clin Infect Dis 2000;31(1):101-106.
77. Corbella X, Montero A, Pujol M, Dominguez MA, Ayats J, Argerich MJ, et al. Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii. J Clin Microbiol 2000;38(11):4086-4095.
78. Mahgoub S, Ahmed J, Glatt AE. Completely resistant Acinetobacter baumannii strains. Infect Control Hosp Epidemiol 2002; 23(8):477-479.
79. Baraibar J, Correa H, Mariscal D, Gallego M, Valles J, Rello J. Risk factors for infection by Acinetobacter baumannii in intubated patients with nosocomial pneumonia. Chest 1997;112(4):1050-1054.
80. Husni RN, Goldstein LS, Arroliga AC, Hall GS, Fatica C, Stoller JK, et al. Risk factors for an outbreak of multi-drug-resistant Acinetobacter nosocomial pneumonia among intubated patients. Chest 1999;115(5):1378-1382.
81. Combes A, Figliolini C, Trouillet JL, Kassis N, Wolff M, Gibert C, et al. Incidence and outcome of polymicrobial ventilator-associated pneumonia. Chest 2002;121(5):1618-1623.
82. Trouillet JL, Chastre J, Vuagnat A, Joly-Guillou ML, Combaux D, Dombret MC, et al. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med 1998; 157(2):531-539.
83. Kollef MH. Treatment of ventilator-associated pneumonia: get it right from the start. Crit Care Med 2003;31(3):969-970.
84. Kollef MH. Appropriate antibiotic therapy for ventilator-associated pneumonia and sepsis: a necessity, not an issue for debate. Intensive Care Med 2003;29(2):147-149.
85. Langer M, Cigada M, Mandelli M, Mosconi P, Tognoni G. Early onset pneumonia: a multicenter study in intensive care units. Intensive Care Med 1987;13(5):342-346.
86. Chevret S, Hemmer M, Carlet J, Langer M. Incidence and risk factors of pneumonia acquired in intensive care units. Results from a multicenter prospective study on 996 patients. European Cooperative Group on Nosocomial Pneumonia. Intensive Care Med 1993; 19(5):256-264.
87. George DL, Falk PS, Wunderink RG, Leeper KV, Jr., Meduri GU, Steere EL, et al. Epidemiology of ventilator-acquired pneumonia based on protected bronchoscopic sampling. Am J Respir Crit Care Med 1998;158(6):1839-1847.
88. Rello J, Sa-Borges M, Correa H, Leal SR, Baraibar J. Variations in etiology of ventilator-associated pneumonia across four treatment sites: Implications for antimicrobial prescribing practices. Am J Respir Crit Care Med 1999;160(2):608-613.
89. Ibrahim EH, Ward S, Sherman G, Kollef MH. A comparative analysis of patients with early-onset vs late-onset nosocomial pneumonia in the ICU setting. Chest 2000; 117(5): 1434-1442.
90. Akca O, Koltka K, Uzel S, Cakar N, Pembeci K, Sayan MA, et al. Risk factors for early-onset, ventilator-associated pneumonia in crit-ical care patients: Selected multiresistant versus nonresistant bacteria. Anesthesiology 2000;93(3):638-645.
91. Leroy O, Meybeck A, d'Escrivan T, Devos P, Kipnis E, Georges H. Impact of adequacy of initial antimicrobial therapy on the prognosis of patients with ventilator-associated pneumonia. Intensive Care Med 2003;29(12):2170-2173.
92. Bochicchio GV, Joshi M, Bochicchio K, Tracy K, Scalea TM. A time-dependent analysis of intensive care unit pneumonia in trauma patients. J Trauma 2004;56(2):296-301;discussion 301-293.
93. Torres A, Carlet J. Ventilator-associated pneumonia. European task force on ventilator-associated pneumonia. Eur Respir J 2001;17(5): 1034-1045.
94. Ewig S, Torres A, El-Ebiary M, Fabregas N, Hernandez C, Gonzalez J, et al. Bacterial colonization patterns in mechanically ventilated patients with traumatic and medical head injury. Incidence, risk factors, and association with ventilator-associated pneumonia. Am J Respir Crit Care Med 1999;159(1):188-198.
95. Babcock HM, Zack JE, Garrison T, Trovillion E, Kollef MH, Fraser VJ. Ventilator-associated pneumonia in a multi-hospital system: Differences in microbiology by location. Infect Control Hosp Epidemiol 2003;24(11):853-858.
96. Namias N, Samiian L, Nino D, Shirazi E, O'Neill K, Kett DH, et al. Incidence and susceptibility of pathogenic bacteria vary between intensive care units within a single hospital: implications for empiric antibiotic strategies. J Trauma 2000;49(4):638-645.
97. Fagon JY, Chastre J, Wolff M, Gervais C, Parer-Aubas S, Stephan F, et al. Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. A randomized trial. Ann Intern Med 2000;132(8):621-630.
98. Dellit TH, Chan JD, Nathens AB, Skerrett SJ, Hooton TM. Development of ventilator-associated pneumonia guidelines based on local microbiology and resistance patterns. Proceedings of the 42nd Annual Meeting of the Infectious Diseases Society of America, 2004 Sept 30-Oct 3, Boston, Massachusetts. A216.
99. Bartlett JG. Anaerobic bacterial infections of the lung. Chest 1987; 91(6):901-909.
100. Bartlett JG, Gorbach SL, Finegold SM. The bacteriology of aspiration pneumonia. Am J Med 1974;56(2):202-207.
101. Robert R, Grollier G, Frat JP, Godet C, Adoun M, Fauchere JL, et al. Colonization of lower respiratory tract with anaerobic bacteria in mechanically ventilated patients. Intensive Care Med 2003;29(7): 1062-1068.
102. Dore P, Robert R, Grollier G, Rouffineau J, Lanquetot H, Charriere JM, et al. Incidence of anaerobes in ventilator-associated pneumonia with use of a protected specimen brush. Am J Respir Crit Care Med 1996;153(4 Pt 1):1292-1298.
103. Grollier G, Dore P, Robert R, Ingrand P, Grejon C, Fauchere JL. Antibody response to Prevotella spp. in patients with ventilator-associated pneumonia. Clin Diagn Lab Immunol 1996;3(1):61-65.
104. Robert R, Grollier G, Dore P, Hira M, Ferrand E, Fauchere JL. Nosocomial pneumonia with isolation of anaerobic bacteria in ICU patients: Therapeutic considerations and outcome. J Crit Care 1999; 14(3):114-119.
105. Marik PE, Careau P. The role of anaerobes in patients with ventilator-associated pneumonia and aspiration pneumonia: a prospective study. Chest 1999;115(1):178-183.
106. Mier L, Dreyfuss D, Darchy B, Lanore JJ, Djedaini K, Weber P, et al. Is penicillin G an adequate initial treatment for aspiration pneumonia? A prospective evaluation using a protected specimen brush and quantitative cultures. Intensive Care Med 1993;19(5):279-284.
107. Lambotte O, Timsit JF, Garrouste-Orgeas M, Misset B, Benali A, Carlet J. The significance of distal bronchial samples with commensals in ventilator-associated pneumonia: colonizer or pathogen? Chest 2002;122(4):1389-1399.
108. Kirby BD, Snyder KM, Meyer RD, Finegold SM. Legionnaires' disease: report of sixty-five nosocomially acquired cases of review of the literature. Medicine (Baltimore) 1980;59(3):188-205.
109. Everts RJ, Murdoch DR, Chambers ST, Town GI, Withington SG, Martin IR, et al. Nosocomial pneumonia in adult general medical and surgical patients at Christchurch hospital. N Z Med J 2000; 113(1111):221-224.
110. Valles J, Mesalles E, Mariscal D, del Mar Fernandez M, Pena R, Jimenez JL, et al. A 7-year study of severe hospital-acquired pneumonia requiring ICU admission. Intensive Care Med 2003;29(11): 1981-1988.
111. Sopena N, Sabria M. Multicenter study of hospital-acquired pneumonia in non-ICU patients. Chest 2005;127(1):213-219.
112. Fields BS, Benson RF, Besser RE. Legionella and Legionnaires' disease: 25 years of investigation. Clin Microbiol Rev 2002;15(3): 506-526.
113. Benin AL, Benson RF, Besser RE. Trends in Legionnaires disease, 1980-1998: declining mortality and new patterns of diagnosis. Clin Infect Dis 2002;35(9):1039-1046.
114. Sabria M, Modol JM, Garcia-Nunez M, Reynaga E, Pedro-Botet ML, Sopena N, et al. Environmental cultures and hospital-acquired Legionnaires' disease: a 5-year prospective study in 20 hospitals in Catalonia, Spain. Infect Control Hosp Epidemiol 2004;25(12):1072-1076.
115. Goetz A, Yu VL. Screening for nosocomial legionellosis by culture of the water supply and targeting of high-risk patients for specialized laboratory testing. Am J Infect Control 1991;19(2):63-66.
116. Goetz AM, Stout JE, Jacobs SL, Fisher MA, Ponzer RE, Drenning S, et al. Nosocomial Legionnaires' disease discovered in community hospitals following cultures of the water system: seek and ye shall find. Am J Infect Control 1998;26(1):8-11.
117. Muder RR, Yu VL. Infection due to Legionella species other than L. pneumophila. Clin Infect Dis 2002;35(8):990-998.
118. Carratala J, Gudiol F, Pallares R, Dorca J, Verdaguer R, Ariza J, et al. Risk factors for nosocomial Legionella pneumophila pneumonia. Am J Respir Crit Care Med 1994;149(3 Pt 1):625-629.
119. Strebel PM, Ramos JM, Eidelman IJ, Tobiansky L, Koornhof HJ, Kustner HG. Legionnaires' disease in a Johannesburg teaching hospital. Investigation and control of an outbreak. S Afr Med J 1988; 73(6):329-333.
120. Arnow PM, Chou T, Weil D, Shapiro EN, Kretzschmar C. Nosocomial Legionnaires' disease caused by aerosolized tap water from respiratory devices. J Infect Dis 1982;146(4):460-467.
121. Mastro TD, Fields BS, Breiman RF, Campbell J, Plikaytis BD, Spika JS. Nosocomial Legionnaires' disease and use of medication nebulizers. J Infect Dis 1991;163(3):667-671.
122. Tablan OC, Anderson LJ, Besser R, Bridges C, Hajjeh R. Guidelines for preventing health-care-associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep 2004;53(RR-3):1-36.
123. Park DR, Skerrett SJ. Il-10 enhances the growth of Legionella pneumophila in human mononuclear phagocytes and reverses the protective effect of IFN-gamma: differential responses of blood monocytes and alveolar macrophages. J Immunol 1996;157(6): 2528-2538.
124. Nash TW, Libby DM, Horwitz MA. Interaction between the Legionnaires' disease bacterium (Legionella pneumophila) and human alveolar macrophages. Influence of antibody, lymphokines, and hydrocortisone. J Clin Invest 1984;74(3):771-782.
125. Nash TW, Libby DM, Horwitz MA. IFN-gamma-activated human alveolar macrophages inhibit the intracellular multiplication of Legionella pneumophila. J Immunol 1988;140(11):3978-3981.
126. Rowbotham TJ. Preliminary report on the pathogenicity of Legionella pneumophila for freshwater and soil amoebae. J Clin Pathol 1980;33(12):1179-1183.
127. Barker J, Brown MR. Trojan horses of the microbial world: protozoa and the survival of bacterial pathogens in the environment. Microbiology 1994;140 (Pt 6):1253-1259.
128. Marrie TJ, Raoult D, La Scola B, Birtles RJ, de Carolis E. Legionella-like and other amoebal pathogens as agents of community-acquired pneumonia. Emerg Infect Dis 2001;7(6):1025-1029.
129. Greub G, Raoult D. Parachlamydiaceae: potential emerging pathogens. Emerg Infect Dis 2002;8(6):625-630.
130. Greub G, Raoult D. Microorganisms resistant to free-living amoebae. Clin Microbiol Rev 2004;17(2):413-433.
131. La Scola B, Boyadjiev I, Greub G, Khamis A, Martin C, Raoult D. Amoeba-resisting bacteria and ventilator-associated pneumonia. Emerg Infect Dis 2003;9(7):815-821.
132. Casalta JP, Piquet P, Alazia M, Guidon-Attali C, Drancourt M, Raoult D. Mycoplasma pneumoniae pneumonia following assisted ventilation. Am J Med 1996;101(2):165-169.
133. Gnarpe J, Lundback A, Sundelof B, Gnarpe H. Prevalence of Mycoplasma pneumoniae in subjectively healthy individuals. Scand J Infect Dis 1992;24(2):161-164.
134. Rumbak MJ, Baselski V, Belenchia JM, Griffin JP. Case report: Acute postoperative respiratory failure caused by Chlamydia pneumoniae and diagnosed by bronchoalveolar lavage. Am J Med Sci 1993;305(6):390-393.
135. Hughes C, Maharg P, Rosario P, Herrell M, Bratt D, Salgado J, et al. Possible nosocomial transmission of psittacosis. Infect Control Hosp Epidemiol 1997;18(3):165-168.
136. Louie M, Dyck B, Parker S, Sekla L, Nicolle LE. Nosocomial pneumonia in a Canadian tertiary care center: a prospective surveillance study. Infect Control Hosp Epidemiol 1991;12(6):356-363.
137. Stott DJ, Kerr G, Carman WF. Nosocomial transmission of influenza. Occup Med (Lond) 2002;52(5):249-253.
138. Carman WF, Elder AG, Wallace LA, McAulay K, Walker A, Murray GD, et al. Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomised controlled trial. Lancet 2000;355(9198):93-97.
139. Ramsey PG, Fife KH, Hackman RC, Meyers JD, Corey L. Herpes simplex virus pneumonia: clinical, virologic, and pathologic features in 20 patients. Ann Intern Med 1982;97(6):813-820.
140. Porteous C, Bradley JA, Hamilton DN, Ledingham IM, Clements GB, Robinson CG. Herpes simplex virus reactivation in surgical patients. Crit Care Med 1984;12(8):626-628.
141. Whitley RJ, Roizman B. Herpes simplex virus infections. Lancet 2001;357(9267):1513-1518.
142. Prellner T, Flamholc L, Haidl S, Lindholm K, Widell A. Herpes simplex virus-the most frequently isolated pathogen in the lungs of patients with severe respiratory distress. Scand J Infect Dis 1992; 24(3):283-292.
143. Tuxen DV, Cade JF, McDonald MI, Buchanan MR, Clark RJ, Pain MC. Herpes simplex virus from the lower respiratory tract in adult respiratory distress syndrome. Am Rev Respir Dis 1982;126(3): 416-419.
144. Tuxen DV, Wilson JW, Cade JF. Prevention of lower respiratory herpes simplex virus infection with acyclovir in patients with the adult respiratory distress syndrome. Am Rev Respir Dis 1987; 136(2):402-405.
145. Tuxen DV. Prevention of lower respiratory herpes simplex virus infection with acyclovir in patients with adult respiratory distress syndrome. Chest 1994;106(1 Suppl):28S-33S.
146. Camps K, Jorens PG, Demey HE, Pattyn SR, Ieven M. Clinical significance of herpes simplex virus in the lower respiratory tract of critically ill patients. Eur J Clin Microbiol Infect Dis 2002;21(10): 758-759.
147. Bruynseels P, Jorens PG, Demey HE, Goossens H, Pattyn SR, Elseviers MM, et al. Herpes simplex virus in the respiratory tract of critical care patients: a prospective study. Lancet 2003;362(9395): 1535-1541.
148. Tanaka S, Toh Y, Minagawa H, Mori R, Sugimachi K, Minamishima Y. Reactivation of cytomegalovirus in patients with cirrhosis: analysis of 122 cases. Hepatology 1992;16(6):1409-1414.
149. Heininger A, Vogel U, Aepinus C, Hamprecht K. Disseminated fatal human cytomegalovirus disease after severe trauma. Crit Care Med 2000;28(2):563-566.
150. Heininger A, Jahn G, Engel C, Notheisen T, Unertl K, Hamprecht K. Human cytomegalovirus infections in nonimmunosuppressed critically ill patients. Crit Care Med 2001;29(3):541-547.
151. Kutza AS, Muhl E, Hackstein H, Kirchner H, Bein G. High incidence of active cytomegalovirus infection among septic patients. Clin Infect Dis 1998;26(5):1076-1082.
152. Papazian L, Fraisse A, Garbe L, Zandotti C, Thomas P, Saux P, et al. Cytomegalovirus. An unexpected cause of ventilator-associated pneumonia. Anesthesiology 1996;84(2):280-287.
153. National nosocomial infections surveillance (NNIS) system report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004;32(8):470-485.
154. El-Ebiary M, Torres A, Fabregas N, de la Bellacasa JP, Gonzalez J, Ramirez J, et al. Significance of the isolation of Candida species from respiratory samples in critically ill, non-neutropenic patients. An immediate postmortem histologic study. Am J Respir Crit Care Med 1997;156(2 Pt 1):583-590.
155. Rello J, Esandi ME, Diaz E, Mariscal D, Gallego M, Valles J. The role of Candida sp isolated from bronchoscopic samples in non-neutropenic patients. Chest 1998;114(1):146-149.
156. Conesa D, Rello J, Valles J, Mariscal D, Ferreres JC. Invasive aspergillosis: a life-threatening complication of short-term steroid treatment. Ann Pharmacother 1995;29(12):1235-1237.
157. Rello J, Esandi ME, Mariscal D, Gallego M, Domingo C, Valles J. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: report of eight cases and review. Clin Infect Dis 1998;26(6):1473-1475.
158. Ibrahim EH, Tracy L, Hill C, Fraser VJ, Kollef MH. The occurrence of ventilator-associated pneumonia in a community hospital: risk factors and clinical outcomes. Chest 2001;120(2):555-561.
159. Meersseman W, Vandecasteele SJ, Wilmer A, Verbeken E, Peetermans WE, Van Wijngaerden E. Invasive aspergillosis in critically ill patients without malignancy. Am J Respir Crit Care Med 2004; 170(6):621-625.
160. Vandewoude K, Blot S, Benoit D, Depuydt P, Vogelaers D, Colardyn F. Invasive aspergillosis in critically ill patients: analysis of risk factors for acquisition and mortality. Acta Clin Belg 2004; 59(5):251-257.
161. Flanagan PG, Barnes RA. Fungal infection in the intensive care unit. J Hosp Infect 1998;38(3):163-177.
162. Shorr AF, Susla GM, O'Grady NP. Pulmonary infiltrates in the non-HIV-infected immunocompromised patient: etiologies, diagnostic strategies, and outcomes. Chest 2004;125(1):260-271.
163. Andrews CP, Coalson JJ, Smith JD, Johanson WG Jr. Diagnosis of nosocomial bacterial pneumonia in acute, diffuse lung injury. Chest 1981;80(3):254-258.
164. Bell RC, Coalson JJ, Smith JD, Johanson WG, Jr. Multiple organ system failure and infection in adult respiratory distress syndrome. Ann Intern Med 1983;99(3):293-298.
165. Montgomery AB, Stager MA, Carrico CJ, Hudson LD. Causes of mortality in patients with the adult respiratory distress syndrome. Am Rev Respir Dis 1985;132(3):485-489.
166. Sutherland KR, Steinberg KP, Maunder RJ, Milberg JA, Allen DL, Hudson LD. Pulmonary infection during the acute respiratory distress syndrome. Am J Respir Crit Care Med 1995;152(2):550-556.
167. Delclaux C, Roupie E, Blot F, Brochard L, Lemaire F, Brun-Buisson C. Lower respiratory tract colonization and infection during severe acute respiratory distress syndrome: incidence and diagnosis. Am J Respir Crit Care Med 1997;156(4 Pt 1):1092-1098.
168. Chastre J, Trouillet JL, Vuagnat A, Joly-Guillou ML, Clavier H, Dombret MC, et al. Nosocomial pneumonia in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 1998; 157(4Pt 1):1165-1172.
169. Meduri GU, Reddy RC, Stanley T, El-Zeky F. Pneumonia in acute respiratory distress syndrome, a prospective evaluation of bilateral bronchoscopic sampling. Am J Respir Crit Care Med 1998;158(3): 870-875.
170. Markowicz P, Wolff M, Djedaini K, Cohen Y, Chastre J, Delclaux C, et al. Multicenter prospective study of ventilator-associated pneumonia during acute respiratory distress syndrome, incidence, prognosis, and risk factors. ARDS Study Group. Am J Respir Crit Care Med 2000;161(6):1942-1948.
171. Georges H, Leroy O, Guery B, Alfandari S, Beaucaire G. Predisposing factors for nosocomial pneumonia in patients receiving mechanical ventilation and requiring tracheotomy. Chest 2000;118(3): 767-774.
172. Rello J, Lorente C, Diaz E, Bodi M, Boque C, Sandiumenge A, et al. Incidence, etiology, and outcome of nosocomial pneumonia in ICU patients requiring percutaneous tracheotomy for mechanical ventilation. Chest 2003;124(6):2239-2243.
173. Hanes SD, Demirkan K, Tolley E, Boucher BA, Croce MA, Wood GC, et al. Risk factors for late-onset nosocomial pneumonia caused by Stenotrophomonas maltophilia in critically ill trauma patients. Clin Infect Dis 2002;35(3):228-235.
174. Rello J, Diaz E, Roque M, Valles J. Risk factors for developing pneumonia within 48 hours of intubation. Am J Respir Crit Care Med 1999;159(6):1742-1746.
175. Jimenez P, Torres A, Rodriguez-Roisin R, de la Bellacasa JP, Aznar R, Gatell JM, et al. Incidence and etiology of pneumonia acquired during mechanical ventilation. Crit Care Med 1989;17(9): 882-885.
176. Torres A, Aznar R, Gatell JM, Jimenez P, Gonzalez J, Ferrer A, et al. Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients. Am Rev Respir Dis 1990;142(3): 523-528.
177. Cunnion KM, Weber DJ, Broadhead WE, Hanson LC, Pieper CF, Rutala WA. Risk factors for nosocomial pneumonia: comparing adult critical-care populations. Am J Respir Crit Care Med 1996; 153(1):158-162.
178. Cook DJ, Walter SD, Cook RJ, Griffith LE, Guyatt GH, Leasa D, et al. Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Intern Med 1998;129(6):433-440.
179. Rello J, Ausina V, Castella J, Net A, Prats G. Nosocomial respiratory tract infections in multiple trauma patients. Influence of level of consciousness with implications for therapy. Chest 1992;102(2): 525-529.
180. Croce MA, Fabian TC, Waddle-Smith L, Melton SM, Minard G, Kudsk KA, et al. Utility of Gram's stain and efficacy of quantitative cultures for posttraumatic pneumonia: a prospective study. Ann Surg 1998;227(5):743- 751;discussion 751-745.
181. Singh N, Falestiny MN, Rogers P, Reed MJ, Pularski J, Norris R, et al. Pulmonary infiltrates in the surgical ICU: prospective assessment of predictors of etiology and mortality. Chest 1998;114(4):1129-1136.
182. Appelgren P, Bjornhagen V, Bragderyd K, Jonsson CE, Ransjo U. A prospective study of infections in burn patients. Burns 2002; 28(1):39-46.
183. Santucci SG, Gobara S, Santos CR, Fontana C, Levin AS. Infections in a burn intensive care unit: experience of seven years. J Hosp Infect 2003;53(1):6-13.
184. Grobmyer SR, Maniscalco SP, Purdue GF, Hunt JL. Alcohol, drug intoxication, or both at the time of burn injury as a predictor of complications and mortality in hospitalized patients with burns. J Burn Care Rehabil 1996;17(6 Pt 1):532-539.
185. Wahl WL, Franklin GA, Brandt MM, Sturm L, Ahrns KS, Hemmila MR, et al. Does bronchoalveolar lavage enhance our ability to treat ventilator-associated pneumonia in a trauma-burn intensive care unit? J Trauma 2003;54(4):633-638.
186. Wahl WL, Ahrns KS, Brandt MM, Rowe SA, Hemmila MR, Arbabi S. Bronchoalveolar lavage in diagnosis of ventilator-associated pneumonia in patients with burns. J Burn Care Rehabil 2005;26(1):57-61.
187. Still J, Newton T, Friedman B, Furhman S, Law E, Dawson J. Experience with pneumonia in acutely burned patients requiring ventilator support. Am Surg 2000;66(2):206-209.
188. de La Cal MA, Cerda E, Garcia-Hierro P, Lorente L, Sanchez-Concheiro M, Diaz C, et al. Pneumonia in patients with severe burns: A classification according to the concept of the carrier state. Chest 2001;119(4):1160-1165.